Mustafa Ali M, Psoter Kevin J, Koehler Kirsten, Lin Nancy, McCormack Meredith, Chen Edward, Wise Robert A, Sharp Michelle
Division of Pulmonary and Critical Care Medicine, Department of Medicine, Johns Hopkins School of Medicine, Baltimore, MD.
Division of General Pediatrics, Department of Pediatrics, Johns Hopkins School of Medicine, Baltimore, MD.
Chest. 2025 Feb;167(2):507-517. doi: 10.1016/j.chest.2024.08.049. Epub 2024 Sep 17.
Sarcoidosis is a granulomatous disease with varying courses of disease progression. Environmental exposures are thought to be contributors to disease onset. Exposure to air pollutants such as fine particulate matter of 2.5 μm diameter or smaller (PM) and nitrogen dioxide (NO) have been identified as contributors to health disparities in lung diseases; little is known about these environmental exposures' associations with disease outcomes in sarcoidosis.
Is higher exposure to PM and NO associated with worse lung function in sarcoidosis?
We conducted a retrospective, cross-sectional study of individuals with pulmonary sarcoidosis seen from 2005 to 2015. Home addresses at the year of enrollment were geocoded, and exposure to PM and NO was modeled using high-resolution 1 km × 1 km annual surface exposure data during the year of enrollment. Racial and sex differences in exposure were determined. Multivariable linear regression models were used to examine the associations between PM and NO and the pulmonary function test measures FVC, FEV, and diffusing capacity of the lungs for carbon monoxide (Dlco).
Among the 415 individuals in the analysis, Black individuals had significantly higher exposure to PM and NO compared with non-Hispanic White individuals, 12.2 μg/m (SD 2.4) vs 11 μg/m (SD 2.2) and 6.3 parts per billion (ppb) (SD 1.9) vs 5.0 ppb (SD 2.0), respectively. Every 1 μg/m higher exposure to PM was associated with 1.12% lower Dlco% predicted (95% CI, -1.83 to -0.41; P < .05). Every 1 ppb higher exposure to NO was associated with 1.04% lower Dlco% predicted (95% CI, -1.91 to -0.18; P < .05) in fully adjusted models. There were no significant associations between these pollutants and either FVC or FEV% predicted.
Higher exposure to PM and NO was associated with worse Dlco% predicted. Black individuals with sarcoidosis were exposed to higher PM and NO than non-Hispanic White individuals. Air pollution exposure may be a contributor to reported health disparities in sarcoidosis.
结节病是一种疾病进展过程各异的肉芽肿性疾病。环境暴露被认为是疾病发病的促成因素。已确定暴露于空气污染物,如直径为2.5微米或更小的细颗粒物(PM)和二氧化氮(NO),是肺部疾病健康差异的促成因素;关于这些环境暴露与结节病疾病结局的关联知之甚少。
在结节病中,更高的PM和NO暴露是否与更差的肺功能相关?
我们对2005年至2015年期间就诊的肺结节病患者进行了一项回顾性横断面研究。对入组年份的家庭住址进行地理编码,并使用入组年份的高分辨率1千米×1千米年度地表暴露数据对PM和NO暴露进行建模。确定了暴露方面的种族和性别差异。使用多变量线性回归模型来检验PM和NO与肺功能测试指标用力肺活量(FVC)、第一秒用力呼气容积(FEV)和肺一氧化碳弥散量(Dlco)之间的关联。
在分析的415名个体中,黑人个体与非西班牙裔白人个体相比,PM和NO暴露显著更高,分别为12.2微克/立方米(标准差2.4) vs 11微克/立方米(标准差2.2)以及6.3十亿分比(ppb)(标准差1.9) vs 5.0 ppb(标准差2.0)。在完全调整模型中,每升高1微克/立方米的PM暴露与预测的Dlco%降低1.12%相关(95%置信区间,-1.83至-0.41;P <.05)。每升高1 ppb的NO暴露与预测的Dlco%降低1.04%相关(95%置信区间,-1.91至-0.18;P <.05)。这些污染物与预测的FVC或FEV%之间无显著关联。
更高的PM和NO暴露与预测的更差的Dlco%相关。结节病黑人个体比非西班牙裔白人个体暴露于更高的PM和NO。空气污染暴露可能是结节病中报告的健康差异的一个促成因素。